Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression
about
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansMeta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymesCarbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array.C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.Glycosylation potential of human prostate cancer cell lines.Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate CancerTumor-Associated Glycans and Immune SurveillanceTwo opposing roles of O-glycans in tumor metastasis.I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signalingRecent progress and perspectives on prostate cancer biomarkers.The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.X-ray crystal structure of leukocyte type core 2 beta1,6-N-acetylglucosaminyltransferase. Evidence for a convergence of metal ion-independent glycosyltransferase mechanism.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerGlycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell ViabilityThe role of glycans in the development and progression of prostate cancer.Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.Galectins: their network and roles in immunity/tumor growth control.Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasisCore 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumorIncreased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
P2860
Q24308236-3E28E96D-DC81-4498-BBC4-7D347AC1ED51Q28085759-3A1BC0A6-1F8E-46DE-B5B3-874B43BE1B84Q33718563-923B4423-5DB6-4DF7-919A-D2954FD7C000Q33809540-201FE0B5-F42E-4688-BD63-C68C0F5F3C32Q34046293-66700BD1-BE70-4F50-B04E-13C6F50D988FQ35782031-331C3C36-9B15-4C6A-B236-0676A87E329DQ35890610-7216447C-4C17-4340-83D8-A82408640B5BQ35972468-6C31B6E7-EE07-433F-943C-4C6AE7FE346BQ36746278-6C2E40CA-48E7-46B7-BC1F-96B5B89E69B8Q37736079-B304C1BC-DA38-406C-BACF-7A60BA96318AQ38259961-75D841A6-CF79-4115-A6ED-1960EFD67794Q38311637-7F4AFC63-68D7-4A46-9332-7A716D2BDBFEQ38544783-0DBEF5BA-5606-45E8-8555-3F1DD919A3F8Q38757500-496A19B4-4B12-44C6-8EA6-C5027889DC9EQ38811520-855D9722-5571-4940-AEBE-3616B4FA4AB5Q38963035-69B5DEA2-A9EE-4E85-AF4D-7BC4E0DF1478Q38969401-579A7CD6-7F43-4499-B7ED-4AFE9E428B14Q39052321-2A6531CA-B20A-4AEB-958F-F7B02070738EQ39141218-83018887-54D5-4316-B386-FEC41502C89AQ39242218-7AB8994A-70B1-4EA2-91C5-1184BF371DFDQ39374390-EE270B65-541E-4F00-B9C9-BD02BA21FF9CQ39762155-A7FA9415-B59E-4BE3-8AAF-CCEA3645D3A9Q46091778-A6CD4241-656A-4AE8-86DB-77686EC32F6CQ54335132-84FA6B9D-71E3-4515-AD51-42337FBB7FAFQ55058557-47AC7342-95A2-49A7-9652-3A65F8455575
P2860
Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@ast
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@en
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@nl
type
label
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@ast
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@en
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@nl
prefLabel
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@ast
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@en
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@nl
P2093
P3181
P356
P1433
P1476
Expression of core 2 beta1,6-N ...... es prostate cancer progression
@en
P2093
Chikara Ohyama
Jun Nakayama
Mareyuki Endoh
Minoru Fukuda
Shigeru Hagisawa
Takuya Moriya
Toshiko Takahashi
Yoichi Arai
P304
P3181
P356
10.1093/GLYCOB/CWI086
P407
P577
2005-10-01T00:00:00Z